China SXT Pharmaceuticals Concludes $12 Million Stock Offering

China SXT Pharmaceuticals Inc. has successfully closed a registered direct offering, raising $12 million. The company sold 8 million Class A ordinary shares to institutional investors at $1.50 per share and issued an equal number of warrants. This capital infusion provides funding for the company's operations and strategic initiatives.